Abstracts

611 – DNA Methylation Clocks Are Altered in Persons With Undetectable HIV and Correlate With Brain Aging

Background DNA methylation (DNAm) clocks are quantitative markers of biological aging. The first-generation Horvath and Hannum clocks closely track actual age, second-generation clocks such as PhenoAge and GrimAge are sensitive to morbidity and mortality, and the third-generation DunedinPACE model estimates individual longitudinal “pace of aging.” Multiple studies have linked HIV infection with increased DNAm age;…

628 – Unmasking the Independent Role of CSF HIV RNA Dynamics by Single Copy Assay in Neurobiotypes

Background In the current study, we test whether low level HIV replication is important in the pathogenesis of neurocognitive and neuroimaging biotypes, and independent of comorbidity and legacy effects. Methods 43 virally-suppressed clinically stable men with HIV (age 53±14 years, plasma and CSF <20-50 cp/mL) were included. Neurocognition, CSF neopterin, plasma and CSF HIV RNA…

600 – Plasma CNS Tissue Markers in Heavily Treatment-Experienced PWH in the PRESTIGIO Registry

Background Heavily treatment-experienced (HTE) persons with HIV (PWH) are characterized by long infection and treatment history, resistant viruses, and a significant burden of concomitant diseases. Since these features may be associated with HIV replication in the Central Nervous System (CNS), this study aimed to assess plasma CNS tissue markers in HTE versus controls. Methods HTE…

599 – Polypharmacy Is Associated With Neuronal Injury in PWH

Background Polypharmacy, or the use of five or more non-ART prescription medications, promote neurologic disorders and geriatric syndromes. However, it is unknown if this is mediated by neuronal damage incurred by multiple medications, by inflammation, or by high comorbidity burden necessitating the use of multiple medications. To better understand how polypharmacy influences neurologic disorder in…

605 – Longitudinal Changes in Neuronal Markers and Associations With ART Initiation and Cognitive Function

Background Improvement in cognitive function is described in persons with HIV commencing ART for the first time. We assessed the impact of initiating either dual or triple ART on longitudinal changes in biomarkers of neuronal inflammation and injury, and their associations with cognitive function. Methods Biomarker concentrations were assessed at baseline (W0) and after 96…

492 – Post-Treatment HIV Controllers Exhibit Reduced Plasma Markers of Inflammation and Metabolic Stress

Background A rare subset of people with HIV (PWH) on antiretroviral therapy (ART), known as post-treatment controllers (PTCs), can maintain viral suppression for extended periods after treatment interruption (TI). The mechanisms underlying this clinically valuable phenotype remain unclear and are likely multifactorial, necessitating further comprehensive analysis. Methods Pre-TI levels of 247 inflammation and immunomodulatory markers…